Amarin (AMRN) Vascepa Pricing Leak?
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as climbing oil, yields amplify inflation fears
- Oil jumps 5%, then pares gains after Trump says no attack on Iran this month
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- CoreWeave stock drops on dilution fears and debt concerns
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
Speculation Heats Up on Amarin (AMRN) After Sales Force Hiring Delayed
November 29, 2012 8:54 AM ESTAmarin Corp Plc (NASDAQ: AMRN) is higher early Thursday amid news the company is delaying the hiring of a sales force until December versus November.
While on the surface this news would seem neutral-to-negative, speculators view this as an indications that... More
Amarin (AMRN) Delays Hiring Vascepa Sales Reps Until Early December
November 29, 2012 7:58 AM ESTAmarin Corporation plc (Nasdaq: AMRN) previously guided that it would make a decision to hire prospective sales representatives as part of its continued Vascepa commercialization preparations before the end of November 2012.
Amarin now expects to make this decision in the first half of... More



